Artificial Kidney Development Takes Leap Forward with New Stem Cell Technology

The global artificial kidney market is valued at US$ 1.5 billion in 2023 and is predicted to surge ahead at a CAGR of 13% to reach a market size of US$ 5.3 billion by the end of 2033. The artificial kidney market refers to the market for medical devices that are designed to perform the functions of a natural kidney in patients who have chronic kidney disease or end-stage renal disease. These devices are also known as renal replacement therapies (RRTs). There are currently two main types of artificial kidneys available on the market: hemodialysis machines and peritoneal dialysis machines. Hemodialysis machines use a filter to remove waste and excess fluids from the blood, while peritoneal dialysis machines use the lining of the patient’s abdomen to filter the blood.

The global artificial kidney market is expected to experience significant growth in the coming years due to the rising prevalence of chronic kidney disease and end-stage renal disease, increasing geriatric population, and technological advancements in renal replacement therapy devices. In addition, the demand for portable and home-based dialysis devices is also expected to increase, driving the growth of the market.

Download Free Sample Copy of this Report –

Key Takeaways from Market Study

  1. Rising prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) is driving the growth of the artificial kidney market.
  2. Technological advancements and innovations in the field of renal replacement therapies (RRT) are leading to the development of more efficient and effective artificial kidneys.
  3. The high cost of kidney transplantation and dialysis is creating a demand for affordable and accessible artificial kidneys.
  4. Government initiatives to support research and development of artificial kidneys are likely to boost market growth.
  5. Key players in the market are investing in strategic partnerships, collaborations, and mergers and acquisitions to expand their product portfolios and enhance their market position.

Regional Analysis

The regional analysis of the artificial kidney market suggests that North America holds the largest market share due to the high prevalence of CKD and ESRD, and the availability of advanced healthcare infrastructure. The presence of major market players, favorable reimbursement policies, and increasing investments in research and development activities for innovative artificial kidney products also contribute to the growth of this region. Furthermore, the growing aging population and the rise in the incidence of diabetes and hypertension are expected to further fuel the market growth in North America.

In Asia Pacific, the market for artificial kidneys is expected to witness significant growth owing to the increasing cases of CKD and ESRD, and the rising demand for affordable and accessible treatment options. The region also offers favorable growth opportunities due to the presence of a large patient pool, increasing healthcare expenditure, and supportive government initiatives to promote the development and adoption of artificial kidneys. Additionally, the presence of emerging economies such as China and India with a large population base and increasing healthcare infrastructure is expected to drive the market growth in the Asia Pacific region

Get Customization on this Report for Specific Research Solutions –

Competitive Landscape

Hantai New Material boosted the yearly production capacity to 2.5 million metres by constructing two new workshops to expand its fire sleeve manufacturing infrastructure to 40 weaving lines and 30 coating lines.

Key Companies Profiled

  • Kawasumi Laboratories Inc.
  • Nanodialysis B.V.
  • Fresenius SE & Co KGaA
  • Baxter
  • Asahi Kasei Medical Co., Ltd.
  • Medtronic
  • DaVita Inc
  • Merit Medical Systems
  • Nipro Medical Corporation
  • Nikkiso Co Ltd
  • B. Braun Melsungen AG
  • AWAK Technologies

Key Segments of Artificial Kidney Industry Research

  • By Type :
    • Wearable Artificial Kidneys
    • Implantable Artificial Kidneys
  • By Dialysis :
    • Hemodialysis
    • Peritoneal Dialysis
    • Combination
  • By Application :
    • Adults
    • Pediatrics
  • By End User :
    • Hospitals
    • Specialty Clinics
    • Ambulatory Surgical Centers

For in-depth competitive analysis, Buy Now –


US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583